ADXN logo

Addex Therapeutics Ltd (ADXN) Company Overview

Profile

Full Name:

Addex Therapeutics Ltd

Sector:

Healthcare

Industry:

Biotechnology

Country:

Switzerland

IPO:

February 12, 2020

Indexes:

Not included

Website:

http://www.addextherapeutics.com

Description:

Addex Therapeutics Ltd is a biopharmaceutical company focused on developing innovative treatments for neurological and psychiatric disorders. They use their proprietary allosteric modulation technology to create drugs that target specific receptors in the brain, aiming to improve patient outcomes in conditions like Parkinson's disease and addiction.

Key Details

Price

$7.70

Market Cap

$8.23 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$1.80 M(+20.44% YoY)

Annual EPS

-$18.71(+67.67% YoY)

PE Ratio

-

Annual ROE

-352.89%

Annual Debt To Equity

0.00

Beta

-

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Aug 18, 2022

Recent annual earnings:

Mar 10, 2022
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Oct 23, 2023

Analyst ratings

Recent major analysts updates

Jul 31, 24 HC Wainwright & Co.
Buy
Jun 23, 22 HC Wainwright & Co.
Neutral
May 31, 22 HC Wainwright & Co.
Buy
Feb 11, 22 HC Wainwright & Co.
Buy
Apr 21, 21 HC Wainwright & Co.
Buy

Screeners with ADXN included

Growing Shares Outstanding
Stocks below SMA 200
Healthcare sector
All stocks
NASDAQ Listed Companies
Biotechnology industry
Small cap stocks
NASDAQ earnings calendar

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$7.70
ADXN price is $7.70

Price All-time High

$483.80
ADXN price is currently -98.41% below its historical high of $483.80

Price Analysts Target

-
ADXN price consensus analysts' forecast is unknown

Price Most Recent Change

-3.75%
ADXN price was down -3.75% on Mar 7, 2025

Price YTD Change

+10%
ADXN price is up +10% since January 1st

Price 3-Year Change

-91.97%
ADXN price is down -91.97% over the past 3 years

Market cap

Market Cap

$8.23 M
ADXN market capitalization is $8.23 million

Market Cap 3-Year Change

-72.82%
ADXN market capitalization is down -72.82% over the past 3 years

Market Cap All-time High

$106.92 M
ADXN market capitalization is currently -92.30% below its historical high of $106.92 million

Market Cap Sector Rank

16.21%
ADXN market capitalization is higher than 16.21% of companies in Healthcare sector

Technical

Beta

-
ADXN beta value is unknown

200-day SMA

$8.66
ADXN price is currently -11.04% below its 200-day simple moving average

14-day RSI

-
ADXN 14-day relative strength index value is unknown

30-day Relative Volume

0.53
ADXN 30-day relative volume is 0.53

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$1.80 M
ADXN annual revenue is $1.80 million

Annual Revenue Analysts Estimate

$1.50 M
ADXN annual revenue is currently +19.75% higher than the consensus analysts' forecast

Annual Revenue 1-Year Change

+20.44%
ADXN annual revenue is up +20.44% year-on-year

Annual Revenue Sector Rank

18.87%
ADXN annual revenue is higher than 18.87% of companies in Healthcare sector

Profit

Annual Gross Profit

-
ADXN annual gross profit value is unknown

Annual Gross Margin

-
ADXN annual gross profit margin value is unknown

Annual Operating Profit

-$11.45 M
ADXN annual operating income is -$11.45 million

Annual Operating Margin

-637.43%
ADXN annual operating profit margin is -637.43%

Annual Net Income

-$11.76 M
ADXN annual net profit is -$11.76 million

Annual Net Margin

-654.47%
ADXN annual net profit margin is -654.47%

EPS

Annual EPS

-$18.71
ADXN annual earnings per share is -$18.71

Annual EPS Analysts Estimate

-
ADXN annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

+67.67%
ADXN annual earnings per share is up +67.67% year-on-year

Annual EPS Sector Rank

11.16%
ADXN annual earnings per share is higher than 11.16% of companies in Healthcare sector

ROA & ROE

Annual ROA

-162.61%
ADXN annual return on assets is -162.61%

Annual ROE

-352.89%
ADXN annual return on equity is -352.89%

EBIT & EBITDA

Annual EBIT

-$11.73 M
ADXN annual earnings before interest & taxes is -$11.73 million

Annual EBITDA

-$11.39 M
ADXN annual EBITDA is -$11.39 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
ADXN price to earnings ratio value is unknown

PE Ratio Sector Rank

-
ADXN price to earnings ratio is unknown

PB Ratio

PB Ratio

0.63
ADXN price to book ratio is 0.63

PB Ratio Sector Rank

32.13%
ADXN price to book ratio is higher than 32.13% of companies in Healthcare sector

PS Ratio

PS Ratio

13.07
ADXN price to sales ratio is 13.07

PS Ratio Sector Rank

80.96%
ADXN price to sales ratio is higher than 80.96% of companies in Healthcare sector

Enterprise value

Enterprise Value

$4.30 M
ADXN enterprise value is $4.30 million

Enterprise Value Sector Rank

17.76%
ADXN enterprise value is higher than 17.76% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.31
ADXN EV/EBITDA is -0.31

EV/EBITDA Sector Rank

57.44%
ADXN EV/EBITDA is higher than 57.44% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

1.46
ADXN annual current ratio is 1.46

Annual Quick Ratio

-
ADXN annual quick ratio value is unknown

Leverage

Annual Debt To Equity

0.00
ADXN annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

-486.80
ADXN annual interest coverage ratio is -486.80

Risk & Stability

Piotroski F-Score

-
ADXN piotroski f-score value is unknown

Altman Z-Score

-113.85
ADXN altman z-score is -113.85

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$5.53 M
ADXN annual total assets is $5.53 million

Annual Non Current Assets

$484.90 K
ADXN annual long term assets is $484.90 thousand

Annual Current Assets

$5.04 M
ADXN annual total current assets is $5.04 million

Annual Cash & Cash Equivalents

$4.60 M
ADXN annual cash & cash equivalents is $4.60 million

Equity

Annual Book Value

$1.36 M
ADXN annual book value is $1.36 million

Annual Working Capital

$1.60 M
ADXN annual working capital is $1.60 million

Liabilities

Annual Total Liabilities

$4.16 M
ADXN annual total liabilities is $4.16 million

Annual Total Long Term Liabilities

$718.10 K
ADXN annual total long term liabilities is $718.10 thousand

Annual Current Liabilities

$3.44 M
ADXN annual total current liabilities is $3.44 million

Annual Accounts Payable

$1.17 M
ADXN annual accounts payable is $1.17 million

Debt

Annual Total Debt

$410.00 K
ADXN annual total debt is $410.00 thousand

Annual Total Debt 1-Year Change

+1.86%
ADXN annual total debt is up +1.86% year-on-year

Annual Long Term Debt

$83.80 K
ADXN annual long term debt is $83.80 thousand

Annual Short Term Debt

$326.20 K
ADXN annual short term debt is $326.20 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$13.25 M
ADXN annual total expenses is $13.25 million

Annual Operating Expenses

$13.25 M
ADXN annual total operating expenses is $13.25 million

Annual Cost Of Goods Sold

-
ADXN annual cost of goods sold value is unknown

Annual SGA

$8.02 M
ADXN annual SGA is $8.02 million

Annual D&A

$340.70 K
ADXN annual depreciation & amortization is $340.70 thousand

Annual Interest Expense

$24.10 K
ADXN annual interest expense is $24.10 thousand

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$8.90 M
ADXN annual cash flow from operations is -$8.90 million

Annual CFO 1-Year Change

+48.36%
ADXN annual cash flow from operations is up +48.36% year-on-year

Annual CFI

-$7600.00
ADXN annual cash flow from investing activities is -$7600.00

Annual CFI 1-Year Change

-345.16%
ADXN annual cash flow from investing activities is down -345.16% year-on-year

Annual CFF

$5.86 M
ADXN annual cash flow from financing activities is $5.86 million

Annual CFF 1-Year Change

+80.22%
ADXN annual cash flow from financing activities is up +80.22% year-on-year

Free CashFlow

Annual FCF

-$8.91 M
ADXN annual free cash flow is -$8.91 million

Annual FCF 1-Year Change

+48.31%
ADXN annual free cash flow is up +48.31% year-on-year

CAPEX

Annual CAPEX

$7600.00
ADXN annual capital expenditures is $7600.00

Annual CAPEX 1-Year Change

+1166.67%
ADXN annual capital expenditures is up +1166.67% year-on-year

Institutional Ownership

Similar stocks

OSA logo
ProSomnus (OSA)
ICU logo
SeaStar Medical Holding (ICU)
RLMD logo
Relmada Therapeutics (RLMD)
Adagio Medical Holdings (ADGM)
MRAI logo
Marpai (MRAI)
MHUA logo
Meihua International Medical Technologies Co (MHUA)
ACXP logo
Acurx Pharmaceuticals (ACXP)
Turnstone Biologics (TSBX)
AYTU logo
Aytu BioPharma (AYTU)

FAQ

  • What is the ticker symbol for Addex Therapeutics Ltd?
  • Does Addex Therapeutics Ltd pay dividends?
  • What sector is Addex Therapeutics Ltd in?
  • What industry is Addex Therapeutics Ltd in?
  • What country is Addex Therapeutics Ltd based in?
  • When did Addex Therapeutics Ltd go public?
  • Is Addex Therapeutics Ltd in the S&P 500?
  • Is Addex Therapeutics Ltd in the NASDAQ 100?
  • Is Addex Therapeutics Ltd in the Dow Jones?
  • When was Addex Therapeutics Ltd's last earnings report?
  • When does Addex Therapeutics Ltd report earnings?

What is the ticker symbol for Addex Therapeutics Ltd?

The ticker symbol for Addex Therapeutics Ltd is NASDAQ:ADXN

Does Addex Therapeutics Ltd pay dividends?

No, Addex Therapeutics Ltd does not pay dividends

What sector is Addex Therapeutics Ltd in?

Addex Therapeutics Ltd is in the Healthcare sector

What industry is Addex Therapeutics Ltd in?

Addex Therapeutics Ltd is in the Biotechnology industry

What country is Addex Therapeutics Ltd based in?

Addex Therapeutics Ltd is headquartered in Switzerland

When did Addex Therapeutics Ltd go public?

Addex Therapeutics Ltd's initial public offering (IPO) was on February 12, 2020

Is Addex Therapeutics Ltd in the S&P 500?

No, Addex Therapeutics Ltd is not included in the S&P 500 index

Is Addex Therapeutics Ltd in the NASDAQ 100?

No, Addex Therapeutics Ltd is not included in the NASDAQ 100 index

Is Addex Therapeutics Ltd in the Dow Jones?

No, Addex Therapeutics Ltd is not included in the Dow Jones index

When was Addex Therapeutics Ltd's last earnings report?

Addex Therapeutics Ltd's most recent earnings report was on Aug 18, 2022

When does Addex Therapeutics Ltd report earnings?

The date for Addex Therapeutics Ltd's next earnings report has not been announced yet